High-risk Breast Cancer
📧 Sign up to get email alerts when something new happens for High-risk Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment [Phase 2]
A Phase 2 neoadjuvant trial is evaluating CDK4/6 inhibitors combined with endocrine therapy for hormone receptor-positive breast cancer; the…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer [Phase 2]
Phase 2 trial evaluating dose escalation tolerability of abemaciclib in HR-positive, HER2-negative early-stage breast cancer; the study is c…